Literature DB >> 9685898

Pharmacokinetic analysis of hepatic uptake of galactosylated bovine serum albumin in a perfused rat liver.

K Ogawara1, M Nishikawa, Y Takakura, M Hashida.   

Abstract

Hepatic uptake of 111In-labelled galactosylated bovine serum albumin (Gal-BSA) with different number of galactose residues per BSA were studied in rat liver perfusion experiments. During a single-pass constant infusion mode, [111In]Gal-BSAs (0.1-2.0 micrograms/ml) were continuously extracted by the liver and its extraction ratio at steady-state (Ess) was lowered as the inflow concentration increased. Hepatic clearance of [111In]Gal-BSAs increased significantly according to the increase in the number of galactose residues per BSA at an inflow concentration of 0.7 micrograms/ml. The outflow patterns of [111In]Gal-BSAs at various inflow concentrations were simultaneously fitted to a one-organ pharmacokinetic model, by which we can characterize their binding to the cell surface and internalization processes separately. The parameters obtained were varied significantly among [111In]Gal-BSAs depending on the number of galactose residues and indicate that not only the binding to the receptors but also the internalization after the binding are regulated by the number of galactose residues per BSA during hepatic uptake.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9685898     DOI: 10.1016/s0168-3659(97)00157-0

Source DB:  PubMed          Journal:  J Control Release        ISSN: 0168-3659            Impact factor:   9.776


  5 in total

Review 1.  Pharmaceutical strategies utilizing recombinant human serum albumin.

Authors:  Victor Tuan Giam Chuang; Ulrich Kragh-Hansen; Masaki Otagiri
Journal:  Pharm Res       Date:  2002-05       Impact factor: 4.200

2.  Evaluation of pullulan-functionalized doxorubicin nanoparticles for asialoglycoprotein receptor-mediated uptake in Hep G2 cell line.

Authors:  Swati A Guhagarkar; Sharmila B Majee; Abdul Samad; Padma V Devarajan
Journal:  Cancer Nanotechnol       Date:  2011-01-27

3.  Pharmacokinetics and preventive effects of targeted catalase derivatives on hydrogen peroxide-induced injury in perfused rat liver.

Authors:  Yoshiyuki Yabe; Naoki Kobayashi; Makiya Nishikawa; Kiyoshi Mihara; Fumiyoshi Yamashita; Yoshinobu Takakura; Mitsuru Hashida
Journal:  Pharm Res       Date:  2002-12       Impact factor: 4.200

4.  Targeting efficiency of galactosylated liposomes to hepatocytes in vivo: effect of lipid composition.

Authors:  Aki Murao; Makiya Nishikawa; Chittima Managit; Joseph Wong; Shigeru Kawakami; Fumiyoshi Yamashita; Mitsuru Hashida
Journal:  Pharm Res       Date:  2002-12       Impact factor: 4.200

5.  Biodistribution characteristics of galactosylated emulsions and incorporated probucol for hepatocyte-selective targeting of lipophilic drugs in mice.

Authors:  Emi Ishida; Chittima Managit; Shigeru Kawakami; Makiya Nishikawa; Fumiyoshi Yamashita; Mitsuru Hashida
Journal:  Pharm Res       Date:  2004-06       Impact factor: 4.200

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.